120 related articles for article (PubMed ID: 6608790)
1. Inhibition of dihydropteridine reductase by novel 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs.
Abell CW; Shen RS; Gessner W; Brossi A
Science; 1984 Apr; 224(4647):405-7. PubMed ID: 6608790
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and dihydropteridine reductase inhibitory effects of potential metabolites of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Gessner W; Brossi A; Shen R; Abell CW
J Med Chem; 1985 Mar; 28(3):311-7. PubMed ID: 3871859
[TBL] [Abstract][Full Text] [Related]
3. Effects of nomifensine and its metabolites on dihydropteridine reductase.
Shen RS; Sheng WL; Abell CW
J Pharm Pharmacol; 1984 Jun; 36(6):411-3. PubMed ID: 6146678
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of dihydropteridine reductase in rat striatal synaptosomes and from human liver by metabolites of biogenic amines.
Shen RS
J Enzyme Inhib; 1985; 1(1):61-6. PubMed ID: 3880425
[TBL] [Abstract][Full Text] [Related]
5. Rat striatal synaptosomes as a model system for studying the inhibition of dihydropteridine reductase activity.
Shen RS; Abell CW
J Enzyme Inhib; 1987; 1(3):223-9. PubMed ID: 3508913
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of dihydropteridine reductase from human liver and rat striatal synaptosomes by apomorphine and its analogs.
Shen RS; Smith RV; Davis PJ; Abell CW
J Biol Chem; 1984 Jul; 259(14):8994-9000. PubMed ID: 6746636
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tyrosine hydroxylation in tissue slices of the rat striatum by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Hirata Y; Nagatsu T
Brain Res; 1985 Jun; 337(1):193-6. PubMed ID: 2860954
[TBL] [Abstract][Full Text] [Related]
8. Aetiology of Parkinson's disease.
Lancet; 1984 Jan; 1(8369):167. PubMed ID: 6140477
[No Abstract] [Full Text] [Related]
9. Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion.
Hirata Y; Nagatsu T
Neurosci Lett; 1985 Jun; 57(3):301-5. PubMed ID: 3929190
[TBL] [Abstract][Full Text] [Related]
10. Dopamine-derived tetrahydroisoquinolines. Novel inhibitors of dihydropteridine reductase.
Shen R; Smith RV; Davis PJ; Brubaker A; Abell CW
J Biol Chem; 1982 Jul; 257(13):7294-7. PubMed ID: 7085626
[TBL] [Abstract][Full Text] [Related]
11. The effect of specific amino acid modifications on the catalytic properties of rat liver dihydropteridine reductase.
Webber S; Whiteley JM
Arch Biochem Biophys; 1981 Jan; 206(1):145-52. PubMed ID: 7212713
[No Abstract] [Full Text] [Related]
12. Inhibition of dihydropteridine reductase by dopamine.
Purdy SE; Blair JA; Barford PA
Biochem J; 1981 Jun; 195(3):769-71. PubMed ID: 7316984
[TBL] [Abstract][Full Text] [Related]
13. Potent inhibitory effects of tyrosine metabolites on dihydropteridine reductase from human and sheep liver.
Shen RS
Biochim Biophys Acta; 1984 Mar; 785(3):181-5. PubMed ID: 6422988
[TBL] [Abstract][Full Text] [Related]
14. Biochemical changes caused by the infusion into the substantia nigra of the rat of MPTP and related compounds which antagonise dihydropteridine reductase.
Bradbury AJ; Brossi A; Costall B; Domeney AM; Gessner W; Naylor RJ
Neuropharmacology; 1986 Jun; 25(6):583-6. PubMed ID: 3489197
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of dihydropteridine reductase by catecholamines and related compounds.
Shen RS
Biochim Biophys Acta; 1983 Feb; 743(1):129-35. PubMed ID: 6824696
[TBL] [Abstract][Full Text] [Related]
16. Rat liver dihydropteridine reductase inhibition.
Purdy SE; Blair JA
Biochem Soc Trans; 1980 Oct; 8(5):565-6. PubMed ID: 7450227
[No Abstract] [Full Text] [Related]
17. Catalytic properties of NADPH-specific dihydropteridine reductase from bovine liver.
Nakanishi N; Hasegawa H; Akino M; Yamada S
J Biochem; 1986 Mar; 99(3):645-52. PubMed ID: 3711040
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of dihydropteridine reductase by catechol estrogens.
Shen RS; Abell CW
J Neurosci Res; 1983; 10(3):251-9. PubMed ID: 6315964
[TBL] [Abstract][Full Text] [Related]
19. Interaction of a photolabile NADH analog with rat liver dihydropteridine reductase.
Webber S; Baumgartner K; Blair JN; Whiteley JM
Biochem Pharmacol; 1988 Jul; 37(14):2869-72. PubMed ID: 3395364
[No Abstract] [Full Text] [Related]
20. Quantitative structure-activity relationship study on some dihydropteridine reductase inhibitors.
Babbar R; Gupta JK; Gupta SP
J Enzyme Inhib; 1989; 2(4):231-7. PubMed ID: 2723771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
